Tokyo Tape
Sign in
← BrightPath Biotherapeutics

Quarterly report · Q2

4594.TEDINET S100S6UQ
Period2023-04-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 45
MetricValuePeriodScopeSource row
Revenue¥44,0002023-04-01 → 2023-09-30StandaloneNet sales
Revenue¥5m2022-04-01 → 2023-03-31StandaloneNet sales (5-year summary)
Revenue¥179,0002022-04-01 → 2022-09-30StandaloneNet sales
Operating income−¥551m2023-04-01 → 2023-09-30StandaloneOperating income
Operating income−¥805m2022-04-01 → 2022-09-30StandaloneOperating income
Ordinary income−¥552m2023-04-01 → 2023-09-30StandaloneOrdinary income
Ordinary income−¥1.5bn2022-04-01 → 2023-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥810m2022-04-01 → 2022-09-30StandaloneOrdinary income
Profit before tax−¥553m2023-04-01 → 2023-09-30StandaloneIncome before income taxes
Profit before tax−¥810m2022-04-01 → 2022-09-30StandaloneIncome before income taxes
Net income−¥554m2023-04-01 → 2023-09-30StandaloneProfit loss
Net income−¥1.5bn2022-04-01 → 2023-03-31StandaloneNet income loss (5-year summary)
Net income−¥811m2022-04-01 → 2022-09-30StandaloneProfit loss
Total assets¥1.2bnat 2023-09-30StandaloneAssets
Total assets¥1.7bnat 2023-03-31StandaloneAssets
Total assets¥2.1bnat 2022-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥150mat 2023-09-30StandaloneLiabilities
Total liabilities¥134mat 2023-03-31StandaloneLiabilities
Net assets / equity¥1.0bnat 2023-09-30StandaloneNet assets
Net assets / equity¥1.6bnat 2023-03-31StandaloneNet assets
Net assets / equity¥2.0bnat 2022-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.1bnat 2023-09-30StandaloneCash and deposits
Cash and deposits¥1.5bnat 2023-03-31StandaloneCash and deposits
Cash & equivalents¥1.1bnat 2023-09-30StandaloneCash and cash equivalents
Cash & equivalents¥1.5bnat 2023-03-31StandaloneCash and cash equivalents
Cash & equivalents¥1.9bnat 2022-09-30StandaloneCash and cash equivalents
Cash & equivalents¥2.3bnat 2022-03-31dStandaloneCash and cash equivalents
Operating cash flow−¥466m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.2bn2022-04-01 → 2023-03-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥589m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥1m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥2m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥432m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥197m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-8.812023-04-01 → 2023-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-4.12023-07-01 → 2023-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-24.92022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-14.22022-04-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-4.522022-07-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio85.4%at 2023-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio90.9%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio93.8%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued62,891,200at 2023-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued62,891,200at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued58,903,100at 2022-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 342
ItemContextValueUnit
Liabilities and net assetsCurrentQuarterInstant_NonConsolidatedMember1163667000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember179000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember44000JPY
Cost of salesPrior1YTDDuration_NonConsolidatedMember44000JPY
Cost of salesCurrentYTDDuration_NonConsolidatedMember11000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember134000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember33000JPY
Selling general and administrative expensesPrior1YTDDuration_NonConsolidatedMember805202000JPY
Selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember550603000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember-805068000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-550569000JPY
Interest income noiPrior1YTDDuration_NonConsolidatedMember11000JPY
Interest income noiCurrentYTDDuration_NonConsolidatedMember6000JPY
Other noiPrior1YTDDuration_NonConsolidatedMember546000JPY
Other noiCurrentYTDDuration_NonConsolidatedMember186000JPY
Non operating incomePrior1YTDDuration_NonConsolidatedMember557000JPY
Non operating incomeCurrentYTDDuration_NonConsolidatedMember193000JPY
Foreign exchange losses noePrior1YTDDuration_NonConsolidatedMember4146000JPY
Foreign exchange losses noeCurrentYTDDuration_NonConsolidatedMember1190000JPY
Stock issuance cost noePrior1YTDDuration_NonConsolidatedMember1073000JPY
Stock issuance cost noeCurrentYTDDuration_NonConsolidatedMember－JPY
Other noePrior1YTDDuration_NonConsolidatedMember61000JPY
Other noeCurrentYTDDuration_NonConsolidatedMember－JPY
Non operating expensesPrior1YTDDuration_NonConsolidatedMember5281000JPY
Non operating expensesCurrentYTDDuration_NonConsolidatedMember1190000JPY
Ordinary incomePrior1YTDDuration_NonConsolidatedMember-809792000JPY
Ordinary incomeCurrentYTDDuration_NonConsolidatedMember-551566000JPY
Impairment loss elPrior1YTDDuration_NonConsolidatedMember－JPY
Impairment loss elCurrentYTDDuration_NonConsolidatedMember1406000JPY
Extraordinary lossPrior1YTDDuration_NonConsolidatedMember－JPY
Extraordinary lossCurrentYTDDuration_NonConsolidatedMember1406000JPY
Income before income taxesPrior1YTDDuration_NonConsolidatedMember-809792000JPY
Income before income taxesCurrentYTDDuration_NonConsolidatedMember-552972000JPY
Income taxes currentPrior1YTDDuration_NonConsolidatedMember950000JPY
Income taxes currentCurrentYTDDuration_NonConsolidatedMember950000JPY
Income taxesPrior1YTDDuration_NonConsolidatedMember950000JPY
Income taxesCurrentYTDDuration_NonConsolidatedMember950000JPY
Profit lossPrior1YTDDuration_NonConsolidatedMember-810742000JPY
Profit lossCurrentYTDDuration_NonConsolidatedMember-553922000JPY
Income before income taxesPrior1YTDDuration_NonConsolidatedMember-809792000JPY
Income before income taxesCurrentYTDDuration_NonConsolidatedMember-552972000JPY
Depreciation and amortization ope cfPrior1YTDDuration_NonConsolidatedMember8359000JPY
Depreciation and amortization ope cfCurrentYTDDuration_NonConsolidatedMember48000JPY
Impairment loss ope cfPrior1YTDDuration_NonConsolidatedMember－JPY
Impairment loss ope cfCurrentYTDDuration_NonConsolidatedMember1406000JPY
Interest and dividends income ope cfPrior1YTDDuration_NonConsolidatedMember-11000JPY
Interest and dividends income ope cfCurrentYTDDuration_NonConsolidatedMember-6000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration_NonConsolidatedMember16506000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration_NonConsolidatedMember24000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration_NonConsolidatedMember-63000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2023-03-31pass
balance sheet identitynon_consolidated 2023-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2023-09-30pass
statement vs summary · operating cash flownon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flownon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · revenuenon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2023-09-30pass